SavedAdd your journal

Journals / Haseki Tıp Bülteni / 2019 / Cilt: 57 - Sayı: 4

Gliosarcoma Transforming from Giant Cell Glioblastoma: A Case Report and Review of the Literature

Dev Hücreli Glioblastomdan Transforme Olan Gliosarkom: Olgu Sunumu ve Literatür Taraması

Muhittin Emre ALTUNRENDE
Elife KIMILOĞLU
Havva Ceren AĞCAKOYUNLU
Osman AKDEMİR
Pages
432–435
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here, we report a case of giant cell glioblastoma transforming to gliosarcoma and review of the literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Giant cell glioblastoma and gliosarcoma are rare histological variants of glioblastoma multiforme.
📊
Key Findings & Data:While giant cell glioblastoma can be seen at younger age, gliosarcoma typically presents at age 40-60 years.
💡
Conclusion & Impact:Here, we report a case of giant cell glioblastoma transforming to gliosarcoma and review of the literature.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Giant cell glioblastoma and gliosarcoma are rare histological variants of glioblastoma multiforme. These are WHO Grade IV astrocytic tumors. While giant cell glioblastoma can be seen at younger age, gliosarcoma typically presents at age 40-60 years. Gliosarcoma has a worse prognosis than giant cell glioblastoma. Here, we report a case of giant cell glioblastoma transforming to gliosarcoma and review of the literature.

Özet

Dev hücre glioblastom ve gliosarkom, glioblastoma multiformenin nadir histolojik varyantıdır. Bunlar WHO Sınıf IV astrositik tümörlerdir. Dev hücreli glioblastom yaşamın erken dönemlerinde görülebilmesine karşın, gliosarkomun yaş ortalaması 40-60 yıldır. Gliosarkom, dev hücre glioblastomdan daha kötü prognoza sahiptir. Biz dev hücre glioblastomadan transforme bir gliosarkom olgusunu ve glial tümörlerde transformasyonla ilgili literatür taramasını sunduk.

🔖

Cite This Article

ALTUNRENDE, M. E., KIMILOĞLU, E., AĞCAKOYUNLU, H. C., AKDEMİR, O. (2022). Gliosarcoma Transforming from Giant Cell Glioblastoma: A Case Report and Review of the Literature. Haseki Tıp Bülteni, Cilt: 57 - Sayı: 4, 432–435. https://ajindex.com/articles/535062

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK.The 2016 World Health Organization Classification of Tumours of the Central Nervous Systems
  2. Edition.International Agency for Research on Cancer (IARC
  3. Zhen H, Yang D, Shen J, et al. Primary gliosarcoma with long-survival: report of two cases and review of literature. Int J Clin EXP Patho 2014;7:6323-32
  4. Yoshida Y, Ide M, Fujimaki H, et al. Gliosarcoma with primitive neuronal, chondroid, osteoid and ependymal elements. Neuropathology 2018
  5. Sugita Y, Terasaki M, Tanigawa K, et al. Gliosarcomas arising from the pineal gland region: uncommon localization and rare tumors. Neuropathology 2016;36:56-63
  6. Deb P, Sharma MC, Chander B, Mahapatra AK, Sarkar C. Giant cell glioblastoma multiforme: report of a case with prolonged survival and transformation to gliosarcoma. Childs Nerv Syst 2006;22:314-9
  7. Mason A, Villavicencio AT, Nelson EW, Forsythe RC, Burneikiene S. Post-treatment gliosarcoma extension into the pterygomaxillary fossa: Literature review and case report. Cureus 2016;8:e700
  8. Pakos EE, Goussia AC, Zina VP, Pitouli EJ, Tsekeris PG. Multi-focal gliosarcoma: a case report and review of the literature. J Neurooncol 2005;74:301-4
  9. Kobayashi T, Sakai K, Tada T, et al. Gliosarcoma arising from a fibrillary astrocytoma. J Clin Neurosci 2011;18:1251-4
  10. Okami N, Kawamata T, Kubo 0, Yamane F, Kawamura H, Hori T. Infantile gliosarcoma: a case and a review of the literature. Childs Nerv Syst 2002;18:351-5
  11. Cheonga J.H, Kim C.H, Kim J.M, Oh Y. Transformation of intracranial anaplastic astrocytoma associated with neurofibromatosis type I into gliosarcoma: Case report. Clin Neurol Neurosurg 2010;112:701-6
  12. Malde R, Jalali R, Muzumdar D, Shet T,Kurkure P. Gliosarcoma occurring 8 years after treatment for a medulloblastoma. Childs Nerv Syst 2004;20:243-6
  13. Yasuda T, Nitta M, Komori T, et al. Gliosarcoma arising from oligodendroglioma, IDH mutant and 1p/19q codeleted. Neuropathology 2018;38:41-6
  14. Cachia D, Kamiya-Matsuoka C, Mandel JJ, etal.Primary and secondary gliosarcomas: clinical, molecular and survival characteristics. J Neurooncol 2015;125:401-10.